Immune research

Antimicrobial peptides: what they do and what studies show

By Dana WhitcombEditorial voice · The Peptide Field

Published October 20, 2026

The short answer

Antimicrobial peptides are amino-acid chains that can kill microbes or slow their growth. The human body makes several kinds as part of its early immune defenses. Defensins, LL-37 and a peptide released from dermcidin are examples. A laboratory result alone cannot establish a treatment's benefit or safety.

See all 6 sources

In this post

A researcher looks through a microscope in a laboratory. — A researcher uses a microscope in this stock photograph. It does not show an antimicrobial peptide sample or a study result.

How they help the body's defenses

Original studies have found antimicrobial peptides in human skin, sweat and the lining of the colon. They form part of the body's early defenses, called innate immunity. Their presence at these surfaces helps explain why researchers study them. It does not establish what happens when a person receives a peptide product.

A 2003 study tested material extracted from normal human colon lining. The mixture had activity against bacteria and fungi in laboratory tests. Researchers also detected LL-37 and several defensins in the material. The finding concerns a mixture from human tissue. It cannot assign every effect to one peptide.

How strong is the evidence? These studies identify molecules and measure laboratory activity. They help explain normal defenses. They do not compare treatments for an infection in people.

Defensins, LL-37 and dermcidin

A 1997 human-skin paper described an antimicrobial peptide called human beta-defensin-2. Defensins are one group within the wider antimicrobial-peptide category. LL-37 comes from a different group, the cathelicidins. These names identify different molecules and groups. They do not give them a shared treatment effect.

A 2001 study examined how human immune cells release LL-37 from a larger starting protein, hCAP18. An enzyme, a protein that helps a chemical reaction, cuts that starting protein. LL-37 is the released peptide. A report naming the larger starting protein is describing a different form.

Another 2001 study identified dermcidin in human sweat glands. The starting protein was cut to release a peptide in sweat. That peptide showed activity against tested microbes, including under salty conditions resembling sweat. This was evidence about a natural defense and laboratory activity. It did not test a treatment in people.

Why the germ and test liquid matter

A 1998 study compared LL-37 with other peptides in laboratory tests. LL-37 disrupted the outer and inner membranes of a tested E. coli strain. Membranes are layers that enclose the bacterial cell. This finding describes one way the peptide acted under those conditions.

The same study found that salt changed some results. Certain microbes resisted LL-37 in the higher-salt test liquid but were susceptible in the lower-salt liquid. Other tested microbes remained susceptible with the added salt. The result depended on both the organism and the test conditions.

The paper therefore supports specific laboratory findings. It does not show that every antimicrobial peptide works against every germ. It also does not establish which product would treat an infection in a person.

How to read a laboratory claim

Consider this hypothetical report: a named peptide stopped one bacterial strain from growing in a low-salt test liquid. The measured outcome is bacterial growth under those conditions. The report has not measured whether people recover from an infection. It also has not measured the harms of giving them that peptide.

To check a real claim, find the exact peptide and germ in the original paper. Then read the test conditions and measured outcome. Check whether the work involved a laboratory sample, an animal or people receiving a treatment. Those details define how far the result can reach.

The sources here explain human examples and selected laboratory findings. They are not a complete review of clinical research on every antimicrobial peptide. For the specific LL-37 question, the existing evidence review separates its research and product limits.

Common questions

Does antimicrobial mean activity against bacteria only?

No. The colon-extract study measured activity against bacteria and fungi. The range depends on the exact material, microbe and test conditions. The name alone does not show which microbes are affected.

The sources below are the record for this post. It was not independently medically reviewed, and it does not diagnose, prescribe, or recommend treatment.

Sources (6)

1. A peptide antibiotic from human skinNature · Original study, 1997; accessible publisher text checked 2. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophilsAntimicrobial Agents and Chemotherapy · Original study, 1998; abstract checked 3. Dermcidin: a novel human antibiotic peptide secreted by sweat glandsNature Immunology · Original study, 2001; abstract checked 4. Antimicrobial peptides in the first line defence of human colon mucosaPeptides · Original study, 2003; abstract checked 5. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3Blood · Original study, 2001; abstract checked 6. Stock microscope photograph and image creditKindel Media · Pexels License · Image credit only

Read the LL-37 evidence

Photos: Kindel Media / Pexels (Pexels License)